期刊
DIABETES
卷 61, 期 12, 页码 3114-3125出版社
AMER DIABETES ASSOC
DOI: 10.2337/db11-1373
关键词
-
资金
- American Diabetes Association [1-10-BS-76, 1-10-JF-54]
- American Heart Association [10GRNT4400005, 12BGIA9050003]
- National Institutes of Health [HL-78679, HL-080569]
- Societe Francophone du Diabete
- Joint Research Fund for Overseas Chinese Young Scholars [31028008]
AMP-activated protein kinase (AMPK) is an essential sensor of cellular energy status. Defects in the alpha 2 catalytic subunit of AMPK (AMPK alpha 1) are associated with metabolic syndrome. The current study investigated the role AMPK alpha 1 in the pathogenesis of obesity and inflammation using male AMPK alpha 1-deficent (AMPK alpha 1(-/-)) mice and their wild-type (WT) littermates. After being fed a high-fat diet (HFD), global AMPK alpha 1(-/-) mice gained more body weight and greater adiposity and exhibited systemic insulin resistance and metabolic dysfunction with increased severity in their adipose tissues compared with their WT littermates. Interestingly, upon HFD feeding, irradiated WT mice that received the bone marrow of AMPK alpha 1(-/-) mice showed increased insulin resistance but not obesity, whereas irradiated AMPK alpha 1(-/-) mice with WT bone marrow had a phenotype of metabolic dysregulation that was similar to that of global AMPK alpha 1(-/-) mice. AMPK alpha 1 deficiency in macrophages markedly increased the macrophage proinflammatory status. In addition, AMPK alpha 1 knockdown enhanced adipocyte lipid accumulation and exacerbated the inflammatory response and insulin resistance. Together, these data show that AMPK alpha 1 protects mice from diet-induced obesity and insulin resistance, demonstrating that AMPK alpha 1 is a promising therapeutic target in the treatment of the metabolic syndrome. Diabetes 61:3114-3125, 2012
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据